The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
Open accessAbstract
Glioblastoma (GBM) is one of the most aggressive and lethal human brain tumors. At present, GBMs are divided in primary and secondary on the basis of the mutational status of the isocitrate dehydrogenase (IDH) genes. In addition, IDH1 and IDH2 mutations are considered crucial to better define the prognosis. Although primary and secondary GBMs are histologically indistinguishable, they retain distinct genetic alterations that account for different evolution of the tumor. The high invasiveness, the propensity to disperse throughout the brain parenchyma, and the elevated vascularity make these tumors extremely recidivist, resulting in a short patient median survival even after surgical resection and chemoradiotherapy. Furthermore, GBM is considered an immunologically cold tumor. Several studies highlight a highly immunosuppressive tumor microenvironment that promotes recurrence and poor prognosis. Deeper insight into the tumor immune microenvironment, together with the recent discovery of a conventional lymphatic system in the central nervous system (CNS), led to new immunotherapeutic strategies. In the last two decades, experimental evidence from different groups proved the existence of cancer stem cells (CSCs), also known as tumor-initiating cells, that may play an active role in tumor development and progression. Recent findings also indicated the presence of highly infiltrative CSCs in the peritumoral region of GBM. This region appears to play a key role in tumor growing and recurrence. However, until recently, few studies investigated the biomolecular characteristics of the peritumoral tissue. The aim of this review is to recapitulate the pathological features of GBM and of the peritumoral region associated with progression and recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Microglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
The role of microglia and macrophages in glioma maintenance and progression
Hambardzumyan, D., Gutmann, D. H., & Kettenmann, H. (2016) · Nature Neuroscience · doi:10.1038/nn.4185 · Cited by 1,683
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., Norrell, H. A., Owens, G., Ransohoff, J., Wilson, C. B., et al. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.49.3.0333 · Cited by 1,667
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., Shi, Q., McLendon, R. E., Bigner, D. D., & Rich, J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1010 · Cited by 1,345
Glioblastoma stem-like cells give rise to tumour endothelium
Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., & Tabar, V. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084 · cited 1×
“While precise mechanisms linking miRNAs to their biological functions are still uncertain, it is clear that the dysregulation of the expression profile of these molecules plays a crucial role in cancer development and progression [84,85].”
BackgroundNeural Stem Cells and the Origin of Gliomas
Sanai, N., Alvarez-Buylla, A., & Berger, M. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043666 · Cited by 1,044
Ignatova, T. N., Kukekov, V. G., Laywell, E. D., Suslov, O. N., Vrionis, F. D., & Steindler, D. A. (2002) · Glia · doi:10.1002/glia.10094 · Cited by 992
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2587 · Cited by 949
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905 · cited 4×
“The complex interactions between the GSCs and the numerous components of the niche may regulate several processes including tumor initiation, survival, and invasion, ultimately affecting the response to therapy [149,150,156].”
BackgroundInfluentialMicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888 · cited 1×
“The contribution of miRNAs to the development and progression of gliomas refers to their regulation of crucial mechanisms, such as apoptosis [86], proliferation and the cell cycle [87,88], the remodeling of the extracellular matrix, tumor infiltration and angiogenesis [86,89], invasiveness [90], stem-cell renewal [91–…”
BackgroundStructural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Engineering vascularized tissue
Jain, R. K., Au, P., Tam, J., Duda, D. G., & Fukumura, D. (2005) · Nature Biotechnology · doi:10.1038/nbt0705-821 · Cited by 808
Isolation of cancer stem cells from adult glioblastoma multiforme
Yuan, X., Curtin, J., Xiong, Y., Liu, G., Waschsmann-Hogiu, S., Farkas, D. L., Black, K. L., & Yu, J. S. (2004) · Oncogene · doi:10.1038/sj.onc.1208311 · Cited by 798
WHO 2016 Classification of gliomas
Wesseling, P., & Capper, D. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12432 · Cited by 795
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Chen, Z., Feng, X., Herting, C. J., Garcia, V. A., Nie, K., Pong, W. W., Rasmussen, R., Dwivedi, B., Seby, S., Wolf, S. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2310 · Cited by 675
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
Chemotherapy resistance of glioblastoma stem cells
Eramo, A., Ricci-Vitiani, L., Zeuner, A., Pallini, R., Lotti, F., Sette, G., Pilozzi, E., Larocca, L. M., Peschle, C., & De Maria, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401872 · Cited by 623
Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., RayChaudhury, A., Newton, H. B., Chiocca, E. A., & Lawler, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2629 · Cited by 587
MGMT testing—the challenges for biomarker-based glioma treatment
Wick, W., Weller, M., van den Bent, M., Sanson, M., Weiler, M., von Deimling, A., Plass, C., Hegi, M., Platten, M., & Reifenberger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.100 · Cited by 579
Gangemi, R. M. R., Griffero, F., Marubbi, D., Perera, M., Capra, M. C., Malatesta, P., Ravetti, G. L., Zona, G. L., Daga, A., & Corte, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0493 · Cited by 578
Glutamate release by primary brain tumors induces epileptic activity
Buckingham, S. C., Campbell, S. L., Haas, B. R., Montana, V., Robel, S., Ogunrinu, T., & Sontheimer, H. (2011) · Nature Medicine · doi:10.1038/nm.2453 · Cited by 578
Current and future strategies for treatment of glioma
Bush, N. A. O., Chang, S. M., & Berger, M. S. (2017) · Neurosurgical Review · doi:10.1007/s10143-016-0709-8 · Cited by 577
Emerging insights into the molecular and cellular basis of glioblastoma
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 565
Immune microenvironment of gliomas
Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.19 · Cited by 538
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
Mechanisms of Glioma-Associated Neovascularization
Hardee, M. E., & Zagzag, D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.06.030 · Cited by 475
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Cook, K. M., & Figg, W. D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20075 · Cited by 474
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
Qazi, M. A., Vora, P., Venugopal, C., Sidhu, S. S., Moffat, J., Swanton, C., & Singh, S. K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx169 · Cited by 408
Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I. R., Wang, X., Eggen, B. J. L., Boddeke, H. W. G. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116644 · Cited by 406
Zhu, T. S., Costello, M. A., Talsma, C. E., Flack, C. G., Crowley, J. G., Hamm, L. L., He, X., Hervey-Jumper, S. L., Heth, J. A., Muraszko, K. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4269 · Cited by 400
Anatomy and physiology of the blood-brain barrier
Serlin, Y., Shelef, I., Knyazer, B., & Friedman, A. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.01.002 · Cited by 397 · cited 1×
“In fact, the brain was always considered a low immune responsive organ [36,37], due to the presence of a highly selective physical blood–brain barrier (BBB), made up by endothelial cells (ECs) stitched together by tight junctions, their basement membrane, surrounding pericytes, and astroglial endfeet processes [38], a…”
BackgroundBurger, P. C., Dubois, P. J., Schold, S. C., Smith, K. R., Odom, G. L., Crafts, D. C., & Giangaspero, F. (1983) · Journal of Neurosurgery · doi:10.3171/jns.1983.58.2.0159 · Cited by 397
Folkins, C., Shaked, Y., Man, S., Tang, T., Lee, C. R., Zhu, Z., Hoffman, R. M., & Kerbel, R. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0167 · Cited by 374
Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15080 · Cited by 344
Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo
Gu, G., Yuan, J., Wills, M., & Kasper, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4608 · Cited by 343
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F., Marubbi, D., Spaziante, R., Bellora, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802845 · Cited by 337
Lohr, J., Ratliff, T., Huppertz, A., Ge, Y., Dictus, C., Ahmadi, R., Grau, S., Hiraoka, N., Eckstein, V., Ecker, R. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2557 · Cited by 337
Advances in Meningeal Immunity
Rua, R., & McGavern, D. B. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.003 · Cited by 326 · cited 1×
“The macromolecules and the immune cells from cerebrospinal fluid and brain parenchyma reach the deep cervical lymph nodes, even if their exact route is still unclear, thereby engaging the peripheral immune system [41,42].”
BackgroundImmunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
Muldoon, L. L., Alvarez, J. I., Begley, D. J., Boado, R. J., del Zoppo, G. J., Doolittle, N. D., Engelhardt, B., Hallenbeck, J. M., Lonser, R. R., Ohlfest, J. R., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.153 · Cited by 321
Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2
Markovic, D. S., Glass, R., Synowitz, M., Rooijen, N. V., & Kettenmann, H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178445.33972.a9 · Cited by 317
Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2
Eyler, C. E., Wu, Q., Yan, K., MacSwords, J. M., Chandler-Militello, D., Misuraca, K. L., Lathia, J. D., Forrester, M. T., Lee, J., Stamler, J. S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.006 · Cited by 309
MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
Medina, R., Zaidi, S. K., Liu, C.-G., Stein, J. L., vanWijnen, A. J., Croce, C. M., & Stein, G. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6754 · Cited by 308
Increased expression of stem cell markers in malignant melanoma
Klein, W. M., Wu, B. P., Zhao, S., Wu, H., Klein-Szanto, A. J. P., & Tahan, S. R. (2007) · Modern Pathology · doi:10.1038/modpathol.3800720 · Cited by 307
Tumor infiltrating immune cells in gliomas and meningiomas
Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruiz, L., Sousa, P., Ciudad, J., Gonçalves, J. M., Lopes, M. C., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.019 · Cited by 302
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Abounader, R., & Laterra, J. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000050 · Cited by 300
Sasayama, T., Nishihara, M., Kondoh, T., Hosoda, K., & Kohmura, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24522 · Cited by 297
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
Lemée, J.-M., Clavreul, A., & Menei, P. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov119 · Cited by 295
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
Roesch, S., Rapp, C., Dettling, S., & Herold-Mende, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020436 · Cited by 293
Zhang, M., Song, T., Yang, L., Chen, R., Wu, L., Yang, Z., & Fang, J. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-85 · Cited by 269
Immune Evasion Strategies of Glioblastoma
Razavi, S.-M., Lee, K. E., Jin, B. E., Aujla, P. S., Gholamin, S., & Li, G. (2016) · Frontiers in Surgery · doi:10.3389/fsurg.2016.00011 · Cited by 262
El‐Kenawi, A. E., & El‐Remessy, A. B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12344 · Cited by 253
Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
Parker, N. R., Khong, P., Parkinson, J. F., Howell, V. M., & Wheeler, H. R. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00055 · Cited by 250
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Huang, Z., Cheng, L., Guryanova, O. A., Wu, Q., & Bao, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0078-y · Cited by 248
Wild-type and mutated IDH1/2 enzymes and therapy responses
Molenaar, R. J., Maciejewski, J. P., Wilmink, J. W., & van Noorden, C. J. F. (2018) · Oncogene · doi:10.1038/s41388-017-0077-z · Cited by 241
Current Standards of Care in Glioblastoma Therapy
Department of Medical Oncology, C. H. D. S. J., FERNANDES, C., COSTA, A., Department of Medical Oncology, C. H. D. S. J., OSÓRIO, L., Department of Radiotherapy, C. H. D. S. J., LAGO, R. C., Department of Radiotherapy, C. H. D. S. J., LINHARES, P., Department of Neurosurgery, C. H. D. S. J., et al. (2017) · Glioblastoma · doi:10.15586/codon.glioblastoma.2017.ch11 · Cited by 234
miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors
Conti, A., Aguennouz, M., La Torre, D., Tomasello, C., Cardali, S., Angileri, F. F., Maio, F., Cama, A., Germanò, A., Vita, G., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9797-4 · Cited by 229
(2017) · Codon Publications eBooks · doi:10.15586/codon.glioblastoma.2017 · Cited by 220
Eisele, G. (2006) · Brain · doi:10.1093/brain/awl205 · Cited by 219
Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments
Streilein, J. W. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90064-y · Cited by 214
Molecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.26 · Cited by 213
Rutledge, W. C., Kong, J., Gao, J., Gutman, D. A., Cooper, L. A. D., Appin, C., Park, Y., Scarpace, L., Mikkelsen, T., Cohen, M. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0551 · Cited by 200
Piccirillo, S. G. M., Combi, R., Cajola, L., Patrizi, A., Redaelli, S., Bentivegna, A., Baronchelli, S., Maira, G., Pollo, B., Mangiola, A., et al. (2009) · Oncogene · doi:10.1038/onc.2009.27 · Cited by 190
Glioblastoma Stem Cells Are Regulated by Interleukin-8 Signaling in a Tumoral Perivascular Niche
Infanger, D. W., Cho, Y., Lopez, B. S., Mohanan, S., Liu, S. C., Gursel, D., Boockvar, J. A., & Fischbach, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1355 · Cited by 184
The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
Zhang, S., Ma, X., Zhu, C., Liu, L., Wang, G., & Yuan, X. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164514 · Cited by 180
Zhang, X., Rao, A., Sette, P., Deibert, C., Pomerantz, A., Kim, W. J., Kohanbash, G., Chang, Y., Park, Y., Engh, J. A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now061 · Cited by 171
Dubinski, D., Wölfer, J., Hasselblatt, M., Schneider-Hohendorf, T., Bogdahn, U., Stummer, W., Wiendl, H., & Grauer, O. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov280 · Cited by 169
MicroRNA in Glioblastoma: An Overview
Banelli, B., Forlani, A., Allemanni, G., Morabito, A., Pistillo, M. P., & Romani, M. (2017) · International Journal of Genomics · doi:10.1155/2017/7639084 · Cited by 168
Natural killer lymphocytes: biology, development, and function
Baxevanis, C. N., Papamichail, M., Perez, S. A., & Gritzapis, A. D. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0478-4 · Cited by 165
Gielen, P. R., Schulte, B. M., Kers-Rebel, E. D., Verrijp, K., Bossman, S. A. J. F. H., ter Laan, M., Wesseling, P., & Adema, G. J. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now034 · Cited by 164
Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
Lathia, J. D., Gallagher, J., Myers, J. T., Li, M., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., Huang, A. Y., & Rich, J. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024807 · Cited by 158
Clark, P. A., Iida, M., Treisman, D. M., Kalluri, H. S. G., Ezhilan, S., Zorniak, M., Wheeler, D. L., & Kuo, J. S. (2012) · Neoplasia · doi:10.1596/neo.12432 · Cited by 156
Emerging molecular mechanisms of brain tumour oedema
Saadoun, S., Saadoun, S., & C., D. (2001) · British Journal of Neurosurgery · doi:10.1080/02688690120036775 · Cited by 149
Ikushima, H., Todo, T., Ino, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300863 · Cited by 145
The role of cancer stem cells in glioblastoma
Sundar, S. J., Hsieh, J. K., Manjila, S. V., Lathia, J. D., & Sloan, A. E. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.9.focus14494 · Cited by 144
Guichet, P., Guelfi, S., Teigell, M., Hoppe, L., Bakalara, N., Bauchet, L., Duffau, H., Lamszus, K., Rothhut, B., & Hugnot, J. (2014) · Stem Cells · doi:10.1002/stem.1767 · Cited by 143
Targeting Aggressive Cancer Stem Cells in Glioblastoma
Seymour, T., Nowak, A. K., & Kakulas, F. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00159 · Cited by 139
Galán‐Moya, E. M., Guelte, A. L., Lima‐Fernandes, E., Thirant, C., Dwyer, J., Bidère, N., Couraud, P., Scott, M. G. H., Junier, M., Chneiweiss, H., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.39 · Cited by 137
Bulstrode, H. J. C. J., Johnstone, E. R., Marqués‐Torrejón, M. Á., Ferguson, K. M., Bressan, R. B., Blin, C., Grant, V., Gogolok, S., Gangoso, E., Gagrica, S., et al. (2017) · Genes & Development · doi:10.1101/gad.293027.116 · Cited by 132
Carén, H., Stricker, S. H., Bulstrode, H. J. C. J., Gagrica, S., Johnstone, E. R., Bartlett, T. E., Feber, A., Wilson, G. A., Teschendorff, A. E., Bertone, P., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.09.014 · Cited by 128
Jiang, Y., & Uhrbom, L. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.658976 · Cited by 128
The role of regulatory T-cells in glioma immunology
Ooi, Y. C., Tran, P., Ung, N. M., Thill, K., Trang, A., Fong, B., Nagasawa, D. T., Lim, M. K., & Yang, I. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.12.004 · Cited by 120
The adaptive immune system in diseases of the central nervous system
Wraith, D. C., & Nicholson, L. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58648 · Cited by 117
Avril, T., Vauléon, É., Hamlat, A., Saïkali, S., Etcheverry, A., Delmas, C., Diabira, S., Mosser, J., & Quillien, V. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00515.x · Cited by 116
Advances in Immunotherapy for Glioblastoma Multiforme
Huang, B., Zhang, H., Gu, L., Ye, B., Jian, Z., Stary, C. M., & Xiong, X. (2017) · Journal of Immunology Research · doi:10.1155/2017/3597613 · Cited by 116
Piccirillo, S. G. M., Dietz, S., Madhu, B., Griffiths, J. R., Price, S. J., Collins, V. P., & Watts, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.271 · Cited by 115
Suter, T., Biollaz, G., Gatto, D., Bernasconi, L., Herren, T., Reith, W., & Fontana, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323611 · Cited by 114 · cited 1×
“In fact, the brain was always considered a low immune responsive organ [36,37], due to the presence of a highly selective physical blood–brain barrier (BBB), made up by endothelial cells (ECs) stitched together by tight junctions, their basement membrane, surrounding pericytes, and astroglial endfeet processes [38], a…”
BackgroundSong, W.-S., Yang, Y., Huang, C.-S., Lu, K., Liu, W., Wu, W.-W., Lee, Y., Lo, W., Lee, S., Chen, Y., et al. (2016) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2016.03.010 · Cited by 111
Diagnosis and Treatment of High-Grade Astrocytoma
Sathornsumetee, S., Rich, J. N., & Reardon, D. A. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.07.004 · Cited by 109
Ruiz-Ontañón, P., Orgaz, J. L., Aldaz, B., Elósegui-Artola, A., Martino, J., Berciano, M. T., Montero, J. A., Grande, L., Nogueira, L., Díaz‐Moralli, S., et al. (2013) · Stem Cells · doi:10.1002/stem.1349 · Cited by 101
Ellert‐Miklaszewska, A., Wiśniewski, P., Kijewska, M., Gajdanowicz, P., Pszczolkowska, D., Przanowski, P., Dąbrowski, M., Maleszewska, M., & Kaminska, B. (2016) · Oncogene · doi:10.1038/onc.2016.55 · Cited by 95
Thirant, C., Galán‐Moya, E. M., Dubois, L. G., Pinte, S., Chafey, P., Broussard, C., Varlet, P., Devaux, B. C., Soncin, F., Gavard, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1062 · Cited by 91
Xia, H., Yan, Y., Hu, M., Wang, Y., Wang, Y., Dai, Y., Chen, J., Di, G., Chen, X., & Jiang, X. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos296 · Cited by 89
Mangiola, A., Lama, G., Giannitelli, C., BONIS, P. D., Anile, C., Lauriola, L., Torre, G. L., Sabatino, G., Maira, G., Jhanwar‐Uniyal, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1229 · Cited by 87
Self-citationMyeloid derived suppressor cells: Targets for therapy
Waldron, T. J., Quatromoni, J. G., Karakasheva, T. A., Singhal, S. K., & Rustgi, A. K. (2013) · OncoImmunology · doi:10.4161/onci.24117 · Cited by 86
Stem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer
Su, H.-T., Weng, C., Hsiao, P., Chen, L., Kuo, T., Chen, Y., Kuo, K., & Cheng, K. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0511 · Cited by 86
López-Bertoni, H., Lal, B., Michelson, N., Guerrero‐Cazares, H., Quiñones-Hinojosa, A., Li, Y., & Laterra, J. (2016) · Oncogene · doi:10.1038/onc.2016.22 · Cited by 75
VEGF Manipulation in Glioblastoma.
Weathers, S.-P. S., & de Groot, J. (2015) · PubMed · Cited by 74
Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia
Hattermann, K., Sebens, S., Helm, O., Schmitt, A. D., Mentlein, R., Mehdorn, H. M., & Held‐Feindt, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3214 · Cited by 70
Immune Suppression: The Hallmark of Myeloid Derived Suppressor Cells
Haile, L. A., Greten, T. F., & Korangy, F. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.680635 · Cited by 70
Cenciarelli, C., Marei, H. E. S., Zonfrillo, M., Pierimarchi, P., Paldino, E., Casalbore, P., Felsani, A., Vescovi, A. L., Maira, G., & Mangiola, A. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-247 · Cited by 66
Musashi1: an RBP with versatile functions in normal and cancer stem cells
Robert, I. G. (2011) · Frontiers in bioscience · doi:10.2741/3915 · Cited by 63
Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo Study
Mangiola, A., Saulnier, N., BONIS, P. D., Orteschi, D., Sica, G., Lama, G., Pettorini, B. L., Sabatino, G., Zollino, M., Lauriola, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057145 · Cited by 62
Self-citationBeyer, S. J., Fleming, J. L., Meng, W., Singh, R., Haque, S., & Chakravarti, A. (2017) · Cancers · doi:10.3390/cancers9070085 · Cited by 62
Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma
Sica, G. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000822 · Cited by 61
Self-citationD’Alessio, A., Proietti, G., Lama, G., Biamonte, F., Lauriola, L., Moscato, U., Vescovi, A. L., Mangiola, A., Angelucci, C., & Sica, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12398 · Cited by 61
Self-citationMiR-181b sensitizes glioma cells to teniposide by targeting MDM2
Sun, Y.-C., Wang, J., Guo, C., Sai, K., Wang, J., Chen, F.-R., Yang, Q., Chen, Y.-S., Wang, J., To, S. S. T., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-611 · Cited by 60
Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages
Zhang, I., Alizadeh, D., Liang, J., Zhang, L., Gao, H., Song, Y., Ren, H., Ouyang, M., Wu, X., D’Apuzzo, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165118 · Cited by 60
Virtual dissection: a lesson from the 18th century
Lukić, I. K., Glunčić, V., Ivkić, G., Hubenstorf, M., & Marušić, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15114-8 · Cited by 58
Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
Scicchitano, B. M., Sorrentino, S., Proietti, G., Lama, G., Dobrowolny, G., Catizone, A., Binda, E., Larocca, L. M., & Sica, G. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0626-8 · Cited by 57
Self-citationTherapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms
Cruceru, M. L., Neagu, M. T., Demoulin, J., & Constantinescu, S. N. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12122 · Cited by 56
The expression of nitric oxide synthases in human brain tumours and peritumoral areas
Bakshi, A., Nag, T. C., Wadhwa, S., Mahapatra, A. K., & Sarkar, C. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00315-8 · Cited by 51
Shi, L., Wan, Y., Sun, G., Gu, X., Qian, C., Yan, W., Zhang, S., Pan, T., Wang, Z., & You, Y. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8188-8 · Cited by 46
Targeting the perivascular niche in brain tumors
Seano, G. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000417 · Cited by 46
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study
Melani, A., Micheli, E. D., Pinna, G., Alfieri, A., Corte, L., & Pedata, F. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00596-2 · Cited by 44
Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue
Lama, G., Mangiola, A., Anile, C., Sabatino, G., BONIS, P. D., Lauriola, L., Giannitelli, C., Torre, G. L., Jhanwar‐Uniyal, M., Sica, G., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.6.1333 · Cited by 43
Self-citationBien-Möller, S., Balz, E., Herzog, S., Plantera, L., Vogelgesang, S., Weitmann, K., Seifert, C., Fink, M. A., Marx, S., Bialke, A., et al. (2018) · Stem Cells International · doi:10.1155/2018/9628289 · Cited by 43
Element distribution is altered in a zone surrounding human glioblastoma multiforme
Dehnhardt, M., Zoriy, M. V., Khan, Z. I., Reifenberger, G., Ekström, T. J., Becker, J. S., Zilles, K., & Bauer, A. (2007) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.08.002 · Cited by 41
Lama, G., Mangiola, A., Proietti, G., Colabianchi, A., Angelucci, C., D’Alessio, A., BONIS, P. D., Geloso, M. C., Lauriola, L., Binda, E., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv012 · Cited by 38
Self-citationBauer, A., Langen, K., Bidmon, H. J., Holschbach, M. H., Weber, S., Olsson, R. A., Coenen, H. H., & Zilles, K. (2005) · PubMed · Cited by 37
Pereira, M. B., Barros, L. R. C., Bracco, P. A., Vigo, Á., Boroni, M., Bonamino, M., & Lenz, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431083 · Cited by 37
Immune surveillance and tumors of the nervous system
Morantz, R. A., Shain, W. G., & Cravioto, H. (1978) · Journal of neurosurgery · doi:10.3171/jns.1978.49.1.0084 · Cited by 36
Immunological characterization of glioblastoma cells for immunotherapy.
Jung, T., Choi, Y. D., Kim, Y., Lee, J., Kim, H.-S., Kim, J.-S., Kim, S., Jung, S., & Cho, D. (2013) · PubMed · Cited by 35
Angelucci, C., D’Alessio, A., Lama, G., Binda, E., Mangiola, A., Vescovi, A. L., Proietti, G., Masuelli, L., Bei, R., Fazi, B., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25565 · Cited by 35
Self-citationDaniel, P. M., Filiz, G., Tymms, M. J., Ramsay, R. G., Kaye, A. H., Stylli, S. S., & Mantamadiotis, T. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.05.009 · Cited by 32
Ultrastructural study of micro-blood vessels in human brain tumors and peritumoral tissue
Roy, S., & Sarkar, C. (1989) · Journal of Neuro-Oncology · doi:10.1007/bf00172922 · Cited by 29
MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells
Deng, Y., Zhu, G., Luo, H., & Zhao, S. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0118 · Cited by 29
Microglia in Cancer: For Good or for Bad?
da Fonseca, A. C. C., do Amaral, R. F., Garcia, C., Geraldo, L. H., Matias, D., & Lima, F. R. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_12 · Cited by 29
STAT-1 expression in human glioblastoma and peritumoral tissue.
Haybaeck, J., Obrist, P., Schindler, C., Spizzo, G., & Doppler, W. (2007) · PubMed · Cited by 23
A microRNA Link to Glioblastoma Heterogeneity
Singh, S. K., Vartanian, A., Burrell, K. E., & Zadeh, G. M. (2012) · Cancers · doi:10.3390/cancers4030846 · Cited by 21
Pilátová, K., Bencsiková, B., Demlová, R., Valík, D., & Dubská, L. Z. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2166-4 · Cited by 21
Zhuang, P., Wang, J., Tang, Z., Zhou, X.-P., Quan, Z.-W., Liu, Y., & Shen, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1763-2 · Cited by 19
(2003) · PubMed
Cited by
Nanocarrier-based drug combination therapy for glioblastoma
Zhao, M., van Straten, D., Broekman, M. L. D., Préat, V., & Schiffelers, R. M. (2020) · Theranostics · doi:10.7150/thno.38147 · Cited by 373
Wu, H., Guo, C., Wang, C., Xu, J., Zheng, S., Duan, J., Li, Y., Bai, H., Xu, Q., Ning, F., et al. (2023) · Cancer Science · doi:10.1111/cas.15773 · Cited by 116
Metadata
- Authors
- D’Alessio, A., Proietti, G., Sica, G., & Scicchitano, B. M.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-04-03
- Volume
- 11
- Issue
- 4
- Pages
- 469
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2926233720
- Cited by
- 275
- References
- 168
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.